Elucida Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Elucida Oncology's estimated annual revenue is currently $3.7M per year.
- Elucida Oncology's estimated revenue per employee is $155,000
Employee Data
- Elucida Oncology has 24 Employees.
- Elucida Oncology grew their employee count by -25% last year.
Elucida Oncology's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | Head Materials Analysis | Reveal Email/Phone |
4 | VP, Technology and CMC | Reveal Email/Phone |
5 | VP | Reveal Email/Phone |
6 | Head Formulation Development, C’ Dot-Drug-Conjugate | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | Associate Director Preclinical Research | Reveal Email/Phone |
9 | Executive Director, Program Management and Principal Consultant | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
Elucida Oncology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is Elucida Oncology?
Elucida Oncology, Inc., is a clinical development stage company based on proprietary ultra-small C-Dot technology to find, see and treat an array of solid tumor cancers. Developed and clinically translated by Memorial Sloan-Kettering Cancer Center and Cornell University, C-Dots have published human safety and tumor-specific clinical data. Elucida Oncology is currently progressing through a broad clinical trial program while continuing to drive a future portfolio through ongoing innovation.
keywords:N/AN/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Elucida Oncology News
MONMOUTH JUNCTION, N.J., April 04, 2022 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company developing the next...
Elucida Oncology, Inc., is a clinical-stage biotechnology company pioneering the next frontier in targeted cancer therapy with its first-in-...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.7M | 24 | 4% | N/A |
#2 | $2.5M | 25 | N/A | N/A |
#3 | $4M | 26 | -10% | N/A |
#4 | $2.2M | 26 | 86% | N/A |
#5 | $4.2M | 27 | 0% | N/A |